title: Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
authors.affiliation: Alzheimer Center, University Hospitals of Cleveland, OH 44106, USA.
authors.forename: P J
authors.initials: PJ
authors.lastname: Whitehouse
authors.forename: J M
authors.initials: JM
authors.lastname: Orgogozo
authors.forename: R E
authors.initials: RE
authors.lastname: Becker
authors.forename: S
authors.initials: S
authors.lastname: Gauthier
authors.forename: M
authors.initials: M
authors.lastname: Pontecorvo
authors.forename: H
authors.initials: H
authors.lastname: Erzigkeit
authors.forename: S
authors.initials: S
authors.lastname: Rogers
authors.forename: R C
authors.initials: RC
authors.lastname: Mohs
authors.forename: N
authors.initials: N
authors.lastname: Bodick
authors.forename: G
authors.initials: G
authors.lastname: Bruno
authors.forename: P
authors.initials: P
authors.lastname: Dal-Bianco
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D002986:Clinical Trials as Topic; D003704:Dementia / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D004339:Drug Compounding; D015577:Geriatric Assessment; D006801:Humans; D007391:International Cooperation; D017410:Practice Guidelines as Topic; D011788:Quality of Life